Cargando…

Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy

Diabetes is associated with a significantly elevated risk of heart failure. However, despite extensive efforts to characterize the phenotype of the diabetic heart, the molecular and cellular protagonists that underpin cardiac pathological remodeling in diabetes remain unclear, with a notable paucity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Charles D., De Blasio, Miles J., Farrugia, Gabriella E., Dona, Malathi S.I., Hsu, Ian, Prakoso, Darnel, Kiriazis, Helen, Krstevski, Crisdion, Nash, David M., Li, Mandy, Gaynor, Taylah L., Deo, Minh, Drummond, Grant R., Ritchie, Rebecca H., Pinto, Alexander R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509303/ https://www.ncbi.nlm.nih.gov/pubmed/37736052 http://dx.doi.org/10.1016/j.isci.2023.107759

Ejemplares similares

Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition
por: Cohen, Charles D., et al.
Publicado: (2021)

A protocol for rapid and parallel isolation of myocytes and non-myocytes from multiple mouse hearts
por: Farrugia, Gabriella E., et al.
Publicado: (2021)

Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes
por: De Blasio, Miles J., et al.
Publicado: (2020)

Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
por: Parker, Alex M., et al.
Publicado: (2021)

Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
por: Prakoso, Darnel, et al.
Publicado: (2021)

Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2019)

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart
por: Tate, Mitchel, et al.
Publicado: (2019)

Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
por: Qin, Cheng Xue, et al.
Publicado: (2017)

Author Correction: Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo
por: Qin, Cheng Xue, et al.
Publicado: (2018)

High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy
por: McLellan, Micheal A., et al.
Publicado: (2020)

Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
por: Phang, Ren Jie, et al.
Publicado: (2022)

Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
por: Becker, Jason R., et al.
Publicado: (2011)

Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy
por: Al Kury, Lina T.
Publicado: (2020)

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2017)

Myocyte [Na(+)](i) Dysregulation in Heart Failure and Diabetic Cardiomyopathy
por: Despa, Sanda
Publicado: (2018)

Eryptosis and Malaria: New Experimental Guidelines and Re-Evaluation of the Antimalarial Potential of Eryptosis Inducers
por: Boulet, Coralie, et al.
Publicado: (2021)

Loss of DNA repair mechanisms in cardiac myocytes induce dilated cardiomyopathy
por: Henpita, Chathurika, et al.
Publicado: (2023)

Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice
por: Dona, Malathi S. I., et al.
Publicado: (2023)

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
por: Voulgari, Christina, et al.
Publicado: (2010)

Loss of CENP-F Results in Dilated Cardiomyopathy with Severe Disruption of Cardiac Myocyte Architecture
por: Manalo, Annabelle, et al.
Publicado: (2018)

Spatial Transcriptomic Analysis of Focal and Normal Areas of Myocyte Disarray in Human Hypertrophic Cardiomyopathy
por: Laird, Jason, et al.
Publicado: (2023)

The Ever-Expanding Landscape of Cardiomyopathies
por: Asatryan, Babken, et al.
Publicado: (2020)

Clinicopathological and Genetic Profiles of Cases with Myocyte Disarray—Investigation for Establishing the Autopsy Diagnostic Criteria for Hypertrophic Cardiomyopathy
por: Hata, Yukiko, et al.
Publicado: (2019)

Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy
por: Ju, Wenhao, et al.
Publicado: (2021)

Red Blood Cell BCL-x(L) Is Required for Plasmodium falciparum Survival: Insights into Host-Directed Malaria Therapies
por: Boulet, Coralie, et al.
Publicado: (2022)

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019)

Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy
por: Pilichou, Kalliopi, et al.
Publicado: (2009)

The α(1H) Ca(2+) channel subunit is expressed in mouse jejunal interstitial cells of Cajal and myocytes
por: Gibbons, Simon J, et al.
Publicado: (2009)

Combinatorial Effects of Double Cardiomyopathy Mutant Alleles in Rodent Myocytes: A Predictive Cellular Model of Myofilament Dysregulation in Disease
por: Davis, Jennifer, et al.
Publicado: (2010)

Subcellular Remodeling in Filamin C Deficient Mouse Hearts Impairs Myocyte Tension Development during Progression of Dilated Cardiomyopathy
por: Powers, Joseph D., et al.
Publicado: (2022)

In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
por: Bernardo, Bianca C., et al.
Publicado: (2022)

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
por: Huynh, Karina, et al.
Publicado: (2010)

Redox signaling in cardiac myocytes
por: Santos, Celio X.C., et al.
Publicado: (2011)

Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in mice
por: Yagisawa, Yuka, et al.
Publicado: (2020)

Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model
por: Iwata, Yuko, et al.
Publicado: (2018)

Longitudinal shortening of sub‐epicardial myocytes in severe ischaemic cardiomyopathy: insights from gadolinium contrast cardiac magnetic resonance imaging
por: Bjerre, Jenny, et al.
Publicado: (2017)

Effect of exercise training on Ca(2+) release units of left ventricular myocytes of spontaneously hypertensive rats
por: Carneiro-Júnior, M.A., et al.
Publicado: (2014)

Landscape of DNA binding signatures of myocyte enhancer factor-2B reveals a unique interplay of base and shape readout
por: Dantas Machado, Ana Carolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ghr0o73edb0eamp7nvr62qo5k